Research ArticleLaboratory Studies
Synthesis and Evaluation of New Iodine-125 Radiopharmaceuticals as Potential Tracers for Malignant Melanoma
Josette M. Michelot, Marie-France C. Moreau, Pierre G. Labarre, Jean-Claude Madelmont, Annie J. Veyre, Janine M. Papon, Daniel F. Parry, Jacques F. Bonafous, Jean-Yves P. Boire, Gerard G. Desplanches, Suzanne J. Bertrand and Gaston Meyniel
Journal of Nuclear Medicine August 1991, 32 (8) 1573-1580;
Josette M. Michelot
Marie-France C. Moreau
Pierre G. Labarre
Jean-Claude Madelmont
Annie J. Veyre
Janine M. Papon
Daniel F. Parry
Jacques F. Bonafous
Jean-Yves P. Boire
Gerard G. Desplanches
Suzanne J. Bertrand
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 32, Issue 8
August 1, 1991
Synthesis and Evaluation of New Iodine-125 Radiopharmaceuticals as Potential Tracers for Malignant Melanoma
Josette M. Michelot, Marie-France C. Moreau, Pierre G. Labarre, Jean-Claude Madelmont, Annie J. Veyre, Janine M. Papon, Daniel F. Parry, Jacques F. Bonafous, Jean-Yves P. Boire, Gerard G. Desplanches, Suzanne J. Bertrand, Gaston Meyniel
Journal of Nuclear Medicine Aug 1991, 32 (8) 1573-1580;
Synthesis and Evaluation of New Iodine-125 Radiopharmaceuticals as Potential Tracers for Malignant Melanoma
Josette M. Michelot, Marie-France C. Moreau, Pierre G. Labarre, Jean-Claude Madelmont, Annie J. Veyre, Janine M. Papon, Daniel F. Parry, Jacques F. Bonafous, Jean-Yves P. Boire, Gerard G. Desplanches, Suzanne J. Bertrand, Gaston Meyniel
Journal of Nuclear Medicine Aug 1991, 32 (8) 1573-1580;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Ultrasensitive detection of malignant melanoma using PET molecular imaging probes
- N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma
- Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52
- 123I-BZA2 as a Melanin-Targeted Radiotracer for the Identification of Melanoma Metastases: Results and Perspectives of a Multicenter Phase III Clinical Trial
- In Vivo Responses of Human A375M Melanoma to a {sigma} Ligand: 18F-FDG PET Imaging
- Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma
- Melanin-Targeted Preclinical PET Imaging of Melanoma Metastasis
- Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA